131 related articles for article (PubMed ID: 3988401)
1. A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane).
Houghton GW; Dennis MJ; Templeton R; Martin BK
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):97-100. PubMed ID: 3988401
[TBL] [Abstract][Full Text] [Related]
2. Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure.
Viron B; De Meyer M; Le Liboux A; Frydman A; Maillard F; Mignon F; Gaillot J
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():95-104. PubMed ID: 2387982
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of zopiclone.
Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
[TBL] [Abstract][Full Text] [Related]
4. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency.
Gaillot J; Le Roux Y; Houghton GW; Dreyfus JF
Sleep; 1987; 10 Suppl 1():7-21. PubMed ID: 3438645
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers.
Caille G; du Souich P; Spenard J; Lacasse Y; Vezina M
Biopharm Drug Dispos; 1984; 5(2):117-25. PubMed ID: 6743780
[TBL] [Abstract][Full Text] [Related]
6. [Zopiclone (imovane)--a new sedative agent].
Wildschiødtz G; Ovesen JO; Clemmesen PH
Ugeskr Laeger; 1989 Feb; 151(8):518-20. PubMed ID: 2922859
[No Abstract] [Full Text] [Related]
7. Residual effects of zopiclone (Imovane).
Broadhurst A; Cushnaghan RC
Sleep; 1987; 10 Suppl 1():48-53. PubMed ID: 3326115
[TBL] [Abstract][Full Text] [Related]
8. Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis.
Marc-Aurele J; Caille G; Bourgoin J
Sleep; 1987; 10 Suppl 1():22-6. PubMed ID: 3438644
[TBL] [Abstract][Full Text] [Related]
9. Dose-finding and premedication studies with zopiclone.
Dundee JW; Elwood RJ; Hildebrand PJ; Singleton M
Int Pharmacopsychiatry; 1982; 17 Suppl 2():210-5. PubMed ID: 7188375
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers.
Lader M; Denney SC
Int Pharmacopsychiatry; 1982; 17 Suppl 2():98-108. PubMed ID: 7188379
[TBL] [Abstract][Full Text] [Related]
11. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
12. [Adverse effects of zopiclone].
Bramness JG; Olsen H
Tidsskr Nor Laegeforen; 1998 May; 118(13):2029-32. PubMed ID: 9656789
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease.
Parker G; Roberts CJ
Br J Clin Pharmacol; 1983 Sep; 16(3):259-65. PubMed ID: 6626417
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopiclone.
Zhao CS; Puurunen K; Schallert T; Sivenius J; Jolkkonen J
Behav Brain Res; 2005 May; 160(2):260-6. PubMed ID: 15863222
[TBL] [Abstract][Full Text] [Related]
15. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
16. Effects of repeated dosing of zopiclone on endocrine system in male rats.
Kawamoto H; Ueno K; Li CK; Kitagawa H; Ohmori S; Igarashi T; Kitagawa H
Res Commun Chem Pathol Pharmacol; 1989 May; 64(2):255-71. PubMed ID: 2740618
[TBL] [Abstract][Full Text] [Related]
17. Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.
Goa KL; Heel RC
Drugs; 1986 Jul; 32(1):48-65. PubMed ID: 2874974
[TBL] [Abstract][Full Text] [Related]
18. Testing for zopiclone in hair application to drug-facilitated crimes.
Villain M; Chèze M; Tracqui A; Ludes B; Kintz P
Forensic Sci Int; 2004 Oct; 145(2-3):117-21. PubMed ID: 15451082
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of zopiclone in disorders of initiating and maintaining sleep. Results of a drug monitoring study in 811 general practices].
Wiegand MH; Roszinsky-Köcher G; Schwalb B; Fischer W; Eckert MW
Fortschr Med Orig; 2001; 119(1):25-32. PubMed ID: 11935654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
